Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 504Genitourinary 284Other hematologic neoplasm 160Plasma cell 65Myeloid 19Sarcoma 17Dermatologic 16Thoracic 10Tumor-Agnostic 8Breast 7Gynecologic 6Gastrointestinal 6CNS 6Other solid neoplasm 2Classical hematology 2Other neoplasm 1Head & Neck 1Endocrine 1

Conditions

Pituitary Neoplasms 1Craniopharyngioma 1

Interventions

Everolimus 59lutetium Lu 177 dotatate 46Magnetic Resonance Spectroscopy 33pembrolizumab 31Temozolomide 31Cisplatin 29Nivolumab 26Octreotide 24lanreotide 23cabozantinib 22pasireotide 21gallium Ga 68 dotatate 21lenvatinib 20Etoposide 19Specimen Handling 18Paclitaxel 18Carboplatin 18Capecitabine 18Sunitinib 17Bevacizumab 16trametinib 15dabrafenib 15Doxorubicin 143-Iodobenzylguanidine 14surufatinib 13Sorafenib 13Ipilimumab 13Thyrotropin Alfa 12Injections 12Positron Emission Tomography Computed Tomography 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Prednisone × Endocrine × Clear all
NCT02190994 2014-07-15

Effect of Perioperative Glucocorticoid Replacement on Prognosis of Surgical Patients With Sellar Lesions

West China Hospital

Phase 4 Unknown
100 enrolled
CNSEndocrine

Craniopharyngioma, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡